BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 24141508)

  • 1. Progressive multifocal leukoencephalopathy: new concepts.
    Lima MA
    Arq Neuropsiquiatr; 2013 Sep; 71(9B):699-702. PubMed ID: 24141508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the management of PML: focus on natalizumab.
    Fox R
    Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S33-7. PubMed ID: 22123933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive multifocal leukoencephalopathy.
    Weissert R
    J Neuroimmunol; 2011 Feb; 231(1-2):73-7. PubMed ID: 20937530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroids for PML-IRIS: a double-edged sword?
    Berger JR
    Neurology; 2009 Apr; 72(17):1454-5. PubMed ID: 19144930
    [No Abstract]   [Full Text] [Related]  

  • 5. Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).
    Bauer J; Gold R; Adams O; Lassmann H
    Acta Neuropathol; 2015 Dec; 130(6):751-64. PubMed ID: 26323992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
    Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
    Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The link between VLA-4 and JC virus reactivation.
    Monaco MC; Major EO
    Expert Rev Clin Immunol; 2012 Jan; 8(1):63-72. PubMed ID: 22149341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases.
    Boren EJ; Cheema GS; Naguwa SM; Ansari AA; Gershwin ME
    J Autoimmun; 2008; 30(1-2):90-8. PubMed ID: 18191544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progressive multifocal leukoencephalopathy--epidemiology, clinical pictures, diagnosis and therapy].
    Kishida S
    Brain Nerve; 2007 Feb; 59(2):125-37. PubMed ID: 17380777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunology of progressive multifocal leukoencephalopathy.
    Jelcic I; Jelcic I; Faigle W; Sospedra M; Martin R
    J Neurovirol; 2015 Dec; 21(6):614-22. PubMed ID: 25740538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
    Lee P; Plavina T; Castro A; Berman M; Jaiswal D; Rivas S; Schlain B; Subramanyam M
    J Clin Virol; 2013 Jun; 57(2):141-6. PubMed ID: 23465394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids.
    Tan K; Roda R; Ostrow L; McArthur J; Nath A
    Neurology; 2009 Apr; 72(17):1458-64. PubMed ID: 19129505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.
    Ishii K; Yamamoto F; Homma S; Okada Y; Nakamichi K; Saijo M; Tamaoka A
    BMC Neurol; 2019 Oct; 19(1):263. PubMed ID: 31672142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on progressive multifocal leukoencephalopathy.
    Steiner I; Berger JR
    Curr Neurol Neurosci Rep; 2012 Dec; 12(6):680-6. PubMed ID: 22991070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Targeted therapy and progressive multifocal leukoencephalopathy (PML): PML in the era of monoclonal antibody therapies].
    Takao M
    Brain Nerve; 2013 Nov; 65(11):1363-74. PubMed ID: 24200614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome.
    Aly L; Yousef S; Schippling S; Jelcic I; Breiden P; Matschke J; Schulz R; Bofill-Mas S; Jones L; Demina V; Linnebank M; Ogg G; Girones R; Weber T; Sospedra M; Martin R
    Brain; 2011 Sep; 134(Pt 9):2687-702. PubMed ID: 21908874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New features of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy and natalizumab.
    Lima MA; Koralnik IJ
    J Neurovirol; 2005; 11 Suppl 3():52-7. PubMed ID: 16540456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human JC polyomavirus (JCPyV): virological background and clinical implications.
    Hirsch HH; Kardas P; Kranz D; Leboeuf C
    APMIS; 2013 Aug; 121(8):685-727. PubMed ID: 23781977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive multifocal leukoencephalopathy in patients with multiple sclerosis.
    Baldwin KJ; Hogg JP
    Curr Opin Neurol; 2013 Jun; 26(3):318-23. PubMed ID: 23493158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive multifocal leukoencephalopathy.
    Aksamit AJ
    Continuum (Minneap Minn); 2012 Dec; 18(6 Infectious Disease):1374-91. PubMed ID: 23221846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.